Life Science CIOs: Map Your Pathway to Digital Trials

Gartner Report

Life Science CIOs: Map Your Pathway to Digital Trials

According to Gartner, “Digital trials are the culmination of new operational technologies.” Digital trials promise lower costs and better patient experience, but CIOs struggle to find their approach. However, there are many shades of gray when it comes to new trial approaches and much confusion around methodologies.

In this report, Gartner dives into the intricacies of digital trials, including:

  1. definitions,
  2. key challenges,
  3. and recommendations.

Medidata is named a Representative vendor in this report to support digitally-driven trials, which have the potential to deliver many advantages including:

  • “Little to no disruption to existing processes, team structure, and workflow.
  • Technology can be introduced as it matures, based on the interplay between business user demand, trial requirements, and ROI.
  • Sponsors can proceed at their own pace and their own tolerance for risk concerning new trial approaches.”

Download the report today for complete insight.

About Gartner

Gartner is the leading technology and research advisory company, working to provide senior technology leaders with indispensable business insights. Gartner provides forward-thinking insights, verified peer-driven research, and robust metrics and data to help technology leaders make the right decisions.

Gartner, Life Science CIOs: Map Your Pathway to Digital Trials, 18 August 2020, Jeff Smith. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Life Science CIOs: Map Your Pathway to Digital Trials